Does active smoking really influence the course of Crohn's disease

Slides:

Advertisements

Similar presentations

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Advertisements

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference Airi Jussila, Lauri J. Virta, Veikko Salomaa,

The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: Differing perceptions from a survey of adult and.

Risk of colorectal cancer and small bowel adenocarcinoma in Crohn's disease: A population-based study from western Hungary 1977–2008 Peter Laszlo Lakatos,

How do psychological variables influence coping strategies in inflammatory bowel disease? Marta Iglesias-Rey, Manuel Barreiro-de Acosta, Francisco Caamaño-Isorna,

Serta Kılınçalp, Akif Altınbaş, Ömer Başar, Murat Deveci, Osman Yüksel

Does the endoscopic appearance of the ileocecal valve suggest the severity of Crohn's disease in the terminal ileum? Tamás Molnár, Klaudia Farkas, Ferenc.

Dermatological adverse reactions during anti-TNF treatments: Focus on inflammatory bowel disease Giammarco Mocci, Manuela Marzo, Alfredo Papa, Alessandro.

Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years

Anti-tumor necrosis factor-α induced systemic lupus erythematosus in a patient with metastatic Crohn's disease—what is the role of anti-TNF antibody?

Concurrent small bowel adenocarcinoma and carcinoid tumor in Crohn's disease — Case report and literature review Doron Boltin, Zohar Levi, Marisa Halpern,

YouTube® and inflammatory bowel disease

Incidence of ulcerative colitis and Crohn's disease in Danish children: Still rising or levelling out? Christian Jakobsen, Vibeke Wewer, Frederikke Urne,

Liver abscess of the caudate lobe due to Staphylococcus aureus in an ulcerative colitis patient: First case report Andreia Albuquerque, Fernando Magro,

Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years

Ineffectiveness of infliximab therapy in severe infantile Crohn's disease Nuray Uslu, Yusuf Usta, Inci Nur Saltik-Temizel, Hulya Demir, Figen Gürakan,

Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: The first case in the literature Gurhan.

Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis Vincent Billioud, Alexander C. Ford,

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference Airi Jussila, Lauri J. Virta, Veikko Salomaa,

High smoking cessation rate in Crohn's disease patients after physician advice – The TABACROHN Study Tiago Nunes, Maria Josefina Etchevers, Olga Merino,

Disease severity does not affect the interval between IBD diagnosis and the development of CRC: Results from two large, Dutch case series Erik Mooiweer,

Prevalence of irritable bowel syndrome (IBS) in first-degree relatives of patients with inflammatory bowel disease (IBD) Mariam Aguas, Vicente Garrigues,

Anterior ischemic optic neuropathy in a patient with Crohn's disease and aberrant MTHFR and GPIIIa gene variants T. Felekis, K.H. Katsanos, C.D. Zois,

Serum prohepcidin levels in chronic inflammatory bowel diseases

Oral tacrolimus for pediatric steroid-resistant ulcerative colitis

Hemophagocytic syndrome in a child with severe Crohn's disease and familial Mediterranean fever Nuray Uslu, Hulya Demir, Gunay Balta, Inci N Saltik-Temizel,

Charlotte de Bie, Angelika Kindermann, Johanna Escher

N. Kjaersgaard Nielsen, V. Wewer, L. Skafte, A. Paerregaard

Hemophagocytic syndrome in a child with severe Crohn's disease and familial Mediterranean fever Nuray Uslu, Hulya Demir, Gunay Balta, Inci N Saltik-Temizel,

Fatal Colonic Perforation in a Pregnant with Behçet's Disease

Filiform polyposis associated with sigmoid diverticulitis in a patient without inflammatory bowel disease Hyun-Soo Kim, Kil Yeon Lee, Youn Wha Kim Journal.

Valle García-Sánchez, Eva Iglesias-Flores, Raúl González, Javier P

Familial aggregation in Crohn's disease and ulcerative colitis in a Norwegian population- based cohort followed for ten years May-Bente Bengtson, Camilla.

Public awareness of Crohn's disease and ulcerative colitis: A national survey Sieglinde Angelberger, Harald Vogelsang, Gottfried Novacek, Wolfgang Miehsler,

B. Sicilia, F. Arribas, J. Nerín, C. López Miguel, R. Vicente, F

Incidence of ulcerative colitis and Crohn's disease in Danish children: Still rising or levelling out? Christian Jakobsen, Vibeke Wewer, Frederikke Urne,

Activated thrombin activatable fibrinolysis inhibitor (TAFIa) is associated with inflammatory markers in inflammatory bowel diseases Danuta Owczarek,

Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease Gord Blackhouse, Nazila Assasi,

W. Dolak, J. Maresch, F. Kainberger, F. Wrba, Ch. Müller

Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature Dana Duricova, Johan Burisch,

Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: A systematic review and meta-analysis Thomas W. Lee, Michael.

Ashwin N. Ananthakrishnan, Millie D. Long, Christopher F

Role of the T-cell interferon-gamma release assays in preventing reactivation of latent tuberculosis infection in immunosuppressed patients in treatment.

Paula Borralho, Ana Vieira, João Freitas, Paula Chaves, Jorge Soares

Clinical trials in luminal Crohn's disease: A historical perspective

M. Chaparro, P. Martínez-Montiel, M. Van Domselaar, F. Bermejo, J. L

Xian-rui Wu, Saurabh Mukewar, Ravi P. Kiran, Feza H

The usefulness of factor XIII levels in Crohn's disease

Genetic variants in autophagy-related genes and granuloma formation in a cohort of surgically treated Crohn's disease patients Marko Brinar, Séverine.

Rapid improvement of refractory pyoderma gangrenosum with infliximab gel in a patient with ulcerative colitis Niels Teich, Tobias Klugmann Journal of.

Seth Lipka, Seymour Katz, Lev Ginzburg Journal of Crohn's and Colitis

Osteoporosis in inflammatory bowel disease

Pediatric pulmonary Crohn's disease: More frequent than expected

Suppurative granulomatous inflammation in the ileo-anal pouch

Ulrich Bonse-Geuking, Michael Kraus Journal of Crohn's and Colitis

Increase in bone mineral density in strictly treated Crohn's disease patients with concomitant calcium and vitamin D supplementation Sjoerd F. Bakker,

Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease Gord Blackhouse, Nazila Assasi,

Fernando Fernández-Bañares, Antonio Salas, Maria Esteve

Yield and cost effectiveness of mycobacterial infection detection using a simple IGRA- based protocol in UK subjects with inflammatory bowel disease suitable.

Genotyping should be considered the primary choice for pre-treatment evaluation of thiopurine methyltransferase function Ulf Hindorf, Malin Lindqvist.

Yinghong Wang, Hua Gong, Rocio Lopez, Lei Lian, Ravi P. Kiran, Edy E

Surgical management of gluteal metastatic cutaneous Crohn's disease

Complete remission of a primary rectal lymphoma on ulcerative colitis, after withdrawal of azathioprine and infliximab Antonio López San Román, Manuel.

Exclusive elemental diet impacts on the gastrointestinal microbiota and improves symptoms in patients with chronic pouchitis S.D. McLaughlin, A. Culkin,

Bowel sonography in occlusive Crohn's disease

The role of in vitro interferonγ-release assay in differentiating intestinal tuberculosis from Crohn's disease in China Yue Li, Li-fan Zhang, Xiao-qing.

Health-related quality of life in inflammatory bowel disease: Psychosocial, clinical, socioeconomic, and demographic predictors Anilga Moradkhani, Linda.

Figure 1 Approximate timeline contrasting major historical events in the understanding of ulcerative colitis (red) and ... Figure 1 Approximate timeline.

Jeffrey Bradley, MD, Issam El Naqa, PhD Journal of Thoracic Oncology

Table of contents The Journal for Nurse Practitioners

Presentation transcript:

Does active smoking really influence the course of Crohn's disease Does active smoking really influence the course of Crohn's disease? A retrospective observational study Yamile Zabana, Esther Garcia-Planella, Manuel Van Domselaar, Míriam Mañosa, Jordi Gordillo, Antonio López San Román, Eduard Cabré, Eugeni Domènech Journal of Crohn's and Colitis Volume 7, Issue 4, Pages 280-285 (May 2013) DOI: 10.1016/j.crohns.2012.03.020 Copyright © 2012 European Crohn's and Colitis Organisation Terms and Conditions

Figure 1 Disease-related events according smoking status at the time of event. Journal of Crohn's and Colitis 2013 7, 280-285DOI: (10.1016/j.crohns.2012.03.020) Copyright © 2012 European Crohn's and Colitis Organisation Terms and Conditions

Figure 2 Treatment requirements regarding smoking status at event. Journal of Crohn's and Colitis 2013 7, 280-285DOI: (10.1016/j.crohns.2012.03.020) Copyright © 2012 European Crohn's and Colitis Organisation Terms and Conditions

Figure 3 Flow chart of patients and major disease-related events according smoking status. Journal of Crohn's and Colitis 2013 7, 280-285DOI: (10.1016/j.crohns.2012.03.020) Copyright © 2012 European Crohn's and Colitis Organisation Terms and Conditions